Languages
  • Deutsch
  • Español
  • français
  • русский
  • العربية
  • info@iozk.de
    • Deutsch Deutsch German de
    • English English English en
    • Español Español Spanish es
    • Русский Русский Russian ru
    IOZK
    • Home
    • The IOZK
      • Philosophy
      • Team
      • Treatment Center
      • Laboratories
      • Directions and Accommodation
      • Patients Pamphlet
    • The IOZK Immunotherapy
      • IOZK Immunotherapy
      • The Vaccine IO-VAC®
      • The Treatment
      • IOZK Immunotherapy for Different Types of Cancer
      • Therapy Costs
      • FAQ
    • Expert Knowledge
      • IOZK Publications
      • Publications
      • Interesting Facts
    • News
    • Contact
    • Search
    • Menu

    Dr. Wilfried Stücker

    Geschäftsführung und Leitung der IOZK Arbeitsgruppe

    The IOZK’s vision: to translate immuno-oncological research insights into practice as soon as possible.

    Dr Wilfried Stücker is the managing director of the IOZK and the IOZK Foundation. In 1985, he initiated the present Immuno-Oncology Centre Cologne. In collaboration with various physicians and scientists, he developed the IOZK immunotherapy and built up the treatment centre with the laboratories.
    The IOZK Foundation was established in 2019 to optimise immunotherapies against cancer.

    „Prolonging the lives of cancer patients and offering them gentle therapy is what we are committed to at the IOZK with our expertise.”

    Dr. Wilfried Stücker

    Collection: Scientific contributions and international publications by Dr Wilfried Stücker

    Nothing Found

    Sorry, no posts matched your criteria

    Further Information on This Topic:

    • Team
    • IOZK Immunotherapy
    • IOZK Foundation

    This post is also available in: German Spanish Russian

    Expert Knowledge

    • Evidence Based Medicine2023-02-01 - 10:15
    • IOZK Laboratories2020-04-29 - 09:03
    • Warmth against Cancer: Therapeutic Hyperthermia2019-06-24 - 14:20
    • What is Immunotherapy?2019-06-24 - 14:18
    • Personalized Medicine in Oncology2019-06-24 - 14:17
    • Viruses Against Cancer: Oncolytic Virotherapy2019-06-24 - 13:53
    • Dendritic Cells Inform the Immune System2019-06-19 - 12:56
    • The Development of Cancer2019-06-19 - 12:52
    • Nobel Prizes for Immunotherapy2019-06-19 - 09:25

    SPECIALISTS IN IMMUNO-ONCOLOGY

    Tags

    Brain Tumor Checkpoint Inhibitors Chemotherapy Dendritic Cells Dr. Wilfried Stücker Hyperthermia Immunotherapy IO-Vac IOZK-Symposium IOZK Immunotherapy IOZK Team of Experts Liquid Biopsy Newcastle Disease Virus Nobel Prize in Medicine Oncology Oncolytic Viruses Paul Ehrlich Award Personalized Medicine Pontine Glioma Prof. Dr. rer. nat. Volker Schirrmacher Prostate Cancer Publications by Stefaan Van Gool MD. PhD. Stefaan Van Gool MD. PhD. Target Therapy Virotherapy
    IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
    Hohenstaufenring 30–32
    50674 Cologne | Germany

    T: +49 (0)221 – 420 399 25
    F: +49(0)221 - 420 399 26
    E-Mail: info@iozk.de

    The IOZK

    • Philosophy
    • Team
    • Treatment Center
    • Laboratories
    • Directions and Accommodation

    The IOZK Immunotherapy

    • IOZK Immunotherapy
    • The Vaccine IO-VAC®
    • The Treatment
    • IOZK Immunotherapy for Different Types of Cancer
    • Therapy Costs
    • FAQ

    News

    • Stefaan van Gool appointed as editor of a special issue by the Journal of Molecular Sciences
    • Award for groundbreaking discovery in immunotherapy goes to Prof. Shimon Sakaguchi
    • Symposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019
    © 2019 IOZK Immun-Onkologisches Zentrum Köln
    • Privacy Statement
    • Cookie Settings
    Scroll to top